Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Liraglutide Injection

Approval Number

S20160005

CompanyNovo Nordisk A/S

Registration Date

April 17, 2020

Previous Approval Numbers

S20160005

Drug Information

Generic Name

利拉鲁肽注射液

Trade Name

诺和力

Dosage Form

注射剂

Strength

3ml:18mg(预填充注射笔)

Drug Type

生物制品

Registration Date

April 17, 2020

Expiry Date

April 16, 2025

Company Information

Applicant Company

Company NameNovo Nordisk A/S

Company Address

Novo Alle, DK-2880 Bagsvaerd, Denmark

Manufacturing Company

Company NameNovo Nordisk A/S

Company Address

Novo Alle, DK-2880 Bagsvaerd, Denmark

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

利拉鲁肽注射液 - NMPA 批准文号 | MedPath